Publication:
A Plain Language Summary of the Cepheus Study of Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone for People With Newly Diagnosed Multiple Myeloma Who Are Not Expected to Receive a Stem Cell Transplant

Research Projects

Organizational Units

Journal Issue

Abstract

Description

Keywords

Citation

WoS Q

Q3

Scopus Q

Q3

Source

Future Oncology

Volume

21

Issue

24

Start Page

3115

End Page

3138

Endorsement

Review

Supplemented By

Referenced By